Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

AN INVESTIGATION INTO THE BRADYCARDIC EFFECTS OF ST 155 [2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HCI] IN THE ANESTHETIZED DOG

R. D. ROBSON, H. R. KAPLAN and SUSANNE LAFORCE
Journal of Pharmacology and Experimental Therapeutics September 1969, 169 (1) 120-131;
R. D. ROBSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. R. KAPLAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUSANNE LAFORCE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

When barbiturate-anesthetized dogs were given pronethalol or guanethidine, ST 155 [2-(2,6-dichiorophenylamino)-2-imidazoline HCI] caused bradycardia and induced bradycardic responses to epinephrine and norepinephrine. The catecholamines and ST 155 initially did not affect heart rate of pronethalol-pretreated dogs, but, with repeated small doses of ST 155, gradually increasing bradycardias were obtained without comparable changes in the pressor effects of these agents. Despite complications introduced by changes in sympathetic tone, the influence of repeated doses of ST 155 was also recognizable in dogs without pronethalol pretreatment. Pronethalol, interruption of pressure-sensitive reflex pathways or the reduction of pressor responses by alpha adrenergic blockade separately modified the size and duration of the bradycardia and in combination abolished the bradycardia of ST 155. In morphine-chloralose-anesthetized dogs, in which heart rate appeared to be largely under vagal control, ST 155 caused bradycardia which was not affected by sympathetic blockade but was abolished by atropine or bilateral vagotomy. These results indicate that, in addition to the reported central suppression of sympathetic outflow, ST 155 can cause bradycardia by enhancing pressuresensitive, compensatory reflexes.

Footnotes

    • Received January 6, 1969.
    • Accepted May 13, 1969.
  • © 1969, by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 169, Issue 1
1 Sep 1969
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
AN INVESTIGATION INTO THE BRADYCARDIC EFFECTS OF ST 155 [2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HCI] IN THE ANESTHETIZED DOG
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

AN INVESTIGATION INTO THE BRADYCARDIC EFFECTS OF ST 155 [2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HCI] IN THE ANESTHETIZED DOG

R. D. ROBSON, H. R. KAPLAN and SUSANNE LAFORCE
Journal of Pharmacology and Experimental Therapeutics September 1, 1969, 169 (1) 120-131;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

AN INVESTIGATION INTO THE BRADYCARDIC EFFECTS OF ST 155 [2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HCI] IN THE ANESTHETIZED DOG

R. D. ROBSON, H. R. KAPLAN and SUSANNE LAFORCE
Journal of Pharmacology and Experimental Therapeutics September 1, 1969, 169 (1) 120-131;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Down-Regulation of Rat Hepatic Microsomal Cytochromes P-450 in Microvesicular Steatosis Induced by Orotic Acid
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics